Side effects with Wegovy 7.2 mg The STEP UP trial found that side effects were somewhat more common at the higher dose: 2 GI side effects: 70.8% (7.2 mg) vs 61.2% (2.4 mg) Dysaesthesia (tingling/numbness): 22.9% (7.2 mg) vs 6.0% (2.4 mg) Discontinuation due to side effects remained low at 3.3% The dysaesthesia finding is notable, though 85.7% of cases resolved while continuing treatment
A balanced approach, one that incorporates both the benefits of NSAIDs and strategies to support overall health, can help individuals make informed choices while minimizing potential risks
However, waist circumference alone accounted for, at most, 33% of the MACE reduction, meaning that semaglutides cardiovascular benefits were not solely based on its impact on waist size
How are sleep, circadian rhythm, stress, and movement patterns influencing metabolism
doi: 10.1007/s10517-005-0406-z 54
You can read more about Type 2 diabetes on the NHS website Type 2 diabetes
